nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Morphine—UGT1A1—hematologic cancer	0.00195	0.191	CrCbGaD
Levorphanol—Estradiol—UGT1A1—hematologic cancer	0.00119	0.117	CrCbGaD
Levorphanol—Estradiol—SLC22A1—hematologic cancer	0.000958	0.0941	CrCbGaD
Levorphanol—Estrone—ABCG2—hematologic cancer	0.000883	0.0867	CrCbGaD
Levorphanol—Estrone—ESR1—hematologic cancer	0.000865	0.085	CrCbGaD
Levorphanol—Estradiol—AR—hematologic cancer	0.000851	0.0836	CrCbGaD
Levorphanol—Estradiol—ABCG2—hematologic cancer	0.000669	0.0657	CrCbGaD
Levorphanol—Estradiol—ESR1—hematologic cancer	0.000655	0.0644	CrCbGaD
Levorphanol—Morphine—ABCB1—hematologic cancer	0.000456	0.0448	CrCbGaD
Levorphanol—Estrone—ALB—hematologic cancer	0.000385	0.0378	CrCbGaD
Levorphanol—Dextromethorphan—ABCB1—hematologic cancer	0.000383	0.0376	CrCbGaD
Levorphanol—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.00038	0.000482	CcSEcCtD
Levorphanol—Gastrointestinal pain—Irinotecan—hematologic cancer	0.00038	0.000482	CcSEcCtD
Levorphanol—Tachycardia—Etoposide—hematologic cancer	0.000377	0.000479	CcSEcCtD
Levorphanol—Abdominal pain—Vincristine—hematologic cancer	0.000377	0.000479	CcSEcCtD
Levorphanol—Shock—Prednisolone—hematologic cancer	0.000375	0.000476	CcSEcCtD
Levorphanol—Hyperhidrosis—Etoposide—hematologic cancer	0.000374	0.000474	CcSEcCtD
Levorphanol—Feeling abnormal—Gemcitabine—hematologic cancer	0.000373	0.000474	CcSEcCtD
Levorphanol—Dizziness—Vinorelbine—hematologic cancer	0.000373	0.000473	CcSEcCtD
Levorphanol—Nausea—Lenalidomide—hematologic cancer	0.000373	0.000473	CcSEcCtD
Levorphanol—Convulsion—Triamcinolone—hematologic cancer	0.000372	0.000473	CcSEcCtD
Levorphanol—Tachycardia—Prednisolone—hematologic cancer	0.000372	0.000472	CcSEcCtD
Levorphanol—Urticaria—Mitoxantrone—hematologic cancer	0.000369	0.000469	CcSEcCtD
Levorphanol—Hyperhidrosis—Prednisolone—hematologic cancer	0.000369	0.000468	CcSEcCtD
Levorphanol—Pruritus—Thalidomide—hematologic cancer	0.000368	0.000468	CcSEcCtD
Levorphanol—Abdominal pain—Mitoxantrone—hematologic cancer	0.000368	0.000466	CcSEcCtD
Levorphanol—Abdominal pain—Irinotecan—hematologic cancer	0.000368	0.000466	CcSEcCtD
Levorphanol—Nausea—Hydroxyurea—hematologic cancer	0.000367	0.000466	CcSEcCtD
Levorphanol—Estrone—ABCB1—hematologic cancer	0.000367	0.0361	CrCbGaD
Levorphanol—Vomiting—Bortezomib—hematologic cancer	0.000367	0.000466	CcSEcCtD
Levorphanol—Vomiting—Bleomycin—hematologic cancer	0.000364	0.000462	CcSEcCtD
Levorphanol—Rash—Bortezomib—hematologic cancer	0.000364	0.000462	CcSEcCtD
Levorphanol—Dermatitis—Bortezomib—hematologic cancer	0.000364	0.000462	CcSEcCtD
Levorphanol—Flushing—Prednisone—hematologic cancer	0.000362	0.000459	CcSEcCtD
Levorphanol—Hypotension—Etoposide—hematologic cancer	0.000361	0.000459	CcSEcCtD
Levorphanol—Rash—Bleomycin—hematologic cancer	0.000361	0.000458	CcSEcCtD
Levorphanol—Dermatitis—Bleomycin—hematologic cancer	0.000361	0.000458	CcSEcCtD
Levorphanol—Vomiting—Vinorelbine—hematologic cancer	0.000358	0.000455	CcSEcCtD
Levorphanol—Dry mouth—Triamcinolone—hematologic cancer	0.000358	0.000454	CcSEcCtD
Levorphanol—Renal failure—Methotrexate—hematologic cancer	0.000357	0.000453	CcSEcCtD
Levorphanol—Dysuria—Epirubicin—hematologic cancer	0.000356	0.000452	CcSEcCtD
Levorphanol—Dizziness—Thiotepa—hematologic cancer	0.000356	0.000452	CcSEcCtD
Levorphanol—Rash—Vinorelbine—hematologic cancer	0.000355	0.000451	CcSEcCtD
Levorphanol—Dermatitis—Vinorelbine—hematologic cancer	0.000355	0.000451	CcSEcCtD
Levorphanol—Pruritus—Alitretinoin—hematologic cancer	0.000351	0.000445	CcSEcCtD
Levorphanol—Arrhythmia—Prednisone—hematologic cancer	0.000349	0.000442	CcSEcCtD
Levorphanol—Sweating—Methotrexate—hematologic cancer	0.000348	0.000442	CcSEcCtD
Levorphanol—Feeling abnormal—Cisplatin—hematologic cancer	0.000348	0.000441	CcSEcCtD
Levorphanol—Pruritus—Ifosfamide—hematologic cancer	0.000346	0.00044	CcSEcCtD
Levorphanol—Shock—Triamcinolone—hematologic cancer	0.000345	0.000438	CcSEcCtD
Levorphanol—Insomnia—Prednisolone—hematologic cancer	0.000345	0.000438	CcSEcCtD
Levorphanol—Dizziness—Thalidomide—hematologic cancer	0.000344	0.000437	CcSEcCtD
Levorphanol—Nausea—Bortezomib—hematologic cancer	0.000343	0.000435	CcSEcCtD
Levorphanol—Tachycardia—Triamcinolone—hematologic cancer	0.000342	0.000434	CcSEcCtD
Levorphanol—Vomiting—Thiotepa—hematologic cancer	0.000342	0.000434	CcSEcCtD
Levorphanol—Nausea—Bleomycin—hematologic cancer	0.00034	0.000432	CcSEcCtD
Levorphanol—Rash—Thiotepa—hematologic cancer	0.000339	0.000431	CcSEcCtD
Levorphanol—Dermatitis—Thiotepa—hematologic cancer	0.000339	0.00043	CcSEcCtD
Levorphanol—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000339	0.00043	CcSEcCtD
Levorphanol—Convulsion—Betamethasone—hematologic cancer	0.000338	0.000429	CcSEcCtD
Levorphanol—Convulsion—Dexamethasone—hematologic cancer	0.000338	0.000429	CcSEcCtD
Levorphanol—Nausea—Vinorelbine—hematologic cancer	0.000335	0.000425	CcSEcCtD
Levorphanol—Renal failure—Epirubicin—hematologic cancer	0.000334	0.000424	CcSEcCtD
Levorphanol—Vomiting—Thalidomide—hematologic cancer	0.000331	0.00042	CcSEcCtD
Levorphanol—Dizziness—Carmustine—hematologic cancer	0.000331	0.00042	CcSEcCtD
Levorphanol—Constipation—Etoposide—hematologic cancer	0.000331	0.00042	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—hematologic cancer	0.00033	0.000419	CcSEcCtD
Levorphanol—Rash—Thalidomide—hematologic cancer	0.000328	0.000417	CcSEcCtD
Levorphanol—Dermatitis—Thalidomide—hematologic cancer	0.000328	0.000416	CcSEcCtD
Levorphanol—Dizziness—Alitretinoin—hematologic cancer	0.000328	0.000416	CcSEcCtD
Levorphanol—Sweating—Epirubicin—hematologic cancer	0.000326	0.000414	CcSEcCtD
Levorphanol—Dizziness—Ifosfamide—hematologic cancer	0.000324	0.000411	CcSEcCtD
Levorphanol—Pruritus—Gemcitabine—hematologic cancer	0.00032	0.000407	CcSEcCtD
Levorphanol—Nausea—Thiotepa—hematologic cancer	0.00032	0.000406	CcSEcCtD
Levorphanol—Feeling abnormal—Etoposide—hematologic cancer	0.000319	0.000404	CcSEcCtD
Levorphanol—Vomiting—Carmustine—hematologic cancer	0.000318	0.000404	CcSEcCtD
Levorphanol—Insomnia—Triamcinolone—hematologic cancer	0.000317	0.000403	CcSEcCtD
Levorphanol—Gastrointestinal pain—Etoposide—hematologic cancer	0.000316	0.000401	CcSEcCtD
Levorphanol—Dizziness—Vincristine—hematologic cancer	0.000316	0.000401	CcSEcCtD
Levorphanol—Rash—Carmustine—hematologic cancer	0.000315	0.0004	CcSEcCtD
Levorphanol—Dermatitis—Carmustine—hematologic cancer	0.000315	0.0004	CcSEcCtD
Levorphanol—Vomiting—Alitretinoin—hematologic cancer	0.000315	0.0004	CcSEcCtD
Levorphanol—Feeling abnormal—Prednisolone—hematologic cancer	0.000314	0.000399	CcSEcCtD
Levorphanol—Visual impairment—Methotrexate—hematologic cancer	0.000314	0.000399	CcSEcCtD
Levorphanol—Shock—Dexamethasone—hematologic cancer	0.000313	0.000397	CcSEcCtD
Levorphanol—Shock—Betamethasone—hematologic cancer	0.000313	0.000397	CcSEcCtD
Levorphanol—Rash—Alitretinoin—hematologic cancer	0.000312	0.000396	CcSEcCtD
Levorphanol—Agitation—Prednisone—hematologic cancer	0.000312	0.000396	CcSEcCtD
Levorphanol—Dermatitis—Alitretinoin—hematologic cancer	0.000312	0.000396	CcSEcCtD
Levorphanol—Vomiting—Ifosfamide—hematologic cancer	0.000311	0.000395	CcSEcCtD
Levorphanol—Tachycardia—Betamethasone—hematologic cancer	0.000311	0.000394	CcSEcCtD
Levorphanol—Tachycardia—Dexamethasone—hematologic cancer	0.000311	0.000394	CcSEcCtD
Levorphanol—Bradycardia—Epirubicin—hematologic cancer	0.000311	0.000394	CcSEcCtD
Levorphanol—Nausea—Thalidomide—hematologic cancer	0.000309	0.000393	CcSEcCtD
Levorphanol—Renal failure—Doxorubicin—hematologic cancer	0.000309	0.000392	CcSEcCtD
Levorphanol—Dyspepsia—Triamcinolone—hematologic cancer	0.000309	0.000392	CcSEcCtD
Levorphanol—Rash—Ifosfamide—hematologic cancer	0.000309	0.000392	CcSEcCtD
Levorphanol—Dermatitis—Ifosfamide—hematologic cancer	0.000308	0.000391	CcSEcCtD
Levorphanol—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000308	0.00039	CcSEcCtD
Levorphanol—Hyperhidrosis—Betamethasone—hematologic cancer	0.000308	0.00039	CcSEcCtD
Levorphanol—Dizziness—Irinotecan—hematologic cancer	0.000307	0.00039	CcSEcCtD
Levorphanol—Urticaria—Etoposide—hematologic cancer	0.000307	0.00039	CcSEcCtD
Levorphanol—Abdominal pain—Etoposide—hematologic cancer	0.000306	0.000388	CcSEcCtD
Levorphanol—Vomiting—Vincristine—hematologic cancer	0.000304	0.000385	CcSEcCtD
Levorphanol—Urticaria—Prednisolone—hematologic cancer	0.000303	0.000385	CcSEcCtD
Levorphanol—Sweating—Doxorubicin—hematologic cancer	0.000301	0.000383	CcSEcCtD
Levorphanol—Rash—Vincristine—hematologic cancer	0.000301	0.000382	CcSEcCtD
Levorphanol—Dermatitis—Vincristine—hematologic cancer	0.000301	0.000382	CcSEcCtD
Levorphanol—Hypotension—Betamethasone—hematologic cancer	0.000297	0.000377	CcSEcCtD
Levorphanol—Hypotension—Dexamethasone—hematologic cancer	0.000297	0.000377	CcSEcCtD
Levorphanol—Nausea—Carmustine—hematologic cancer	0.000297	0.000377	CcSEcCtD
Levorphanol—Vomiting—Irinotecan—hematologic cancer	0.000296	0.000375	CcSEcCtD
Levorphanol—Vomiting—Mitoxantrone—hematologic cancer	0.000296	0.000375	CcSEcCtD
Levorphanol—Nausea—Alitretinoin—hematologic cancer	0.000294	0.000373	CcSEcCtD
Levorphanol—Convulsion—Prednisone—hematologic cancer	0.000294	0.000373	CcSEcCtD
Levorphanol—Visual impairment—Epirubicin—hematologic cancer	0.000294	0.000373	CcSEcCtD
Levorphanol—Rash—Irinotecan—hematologic cancer	0.000293	0.000372	CcSEcCtD
Levorphanol—Rash—Mitoxantrone—hematologic cancer	0.000293	0.000372	CcSEcCtD
Levorphanol—Dermatitis—Irinotecan—hematologic cancer	0.000293	0.000372	CcSEcCtD
Levorphanol—Dermatitis—Mitoxantrone—hematologic cancer	0.000293	0.000372	CcSEcCtD
Levorphanol—Estradiol—ALB—hematologic cancer	0.000292	0.0287	CrCbGaD
Levorphanol—Nausea—Ifosfamide—hematologic cancer	0.000291	0.000369	CcSEcCtD
Levorphanol—Feeling abnormal—Triamcinolone—hematologic cancer	0.000289	0.000367	CcSEcCtD
Levorphanol—Vomiting—Gemcitabine—hematologic cancer	0.000288	0.000365	CcSEcCtD
Levorphanol—Insomnia—Dexamethasone—hematologic cancer	0.000288	0.000365	CcSEcCtD
Levorphanol—Insomnia—Betamethasone—hematologic cancer	0.000288	0.000365	CcSEcCtD
Levorphanol—Bradycardia—Doxorubicin—hematologic cancer	0.000287	0.000365	CcSEcCtD
Levorphanol—Rash—Gemcitabine—hematologic cancer	0.000286	0.000362	CcSEcCtD
Levorphanol—Dermatitis—Gemcitabine—hematologic cancer	0.000285	0.000362	CcSEcCtD
Levorphanol—Nausea—Vincristine—hematologic cancer	0.000284	0.00036	CcSEcCtD
Levorphanol—Flushing—Epirubicin—hematologic cancer	0.000283	0.000359	CcSEcCtD
Levorphanol—Dyspepsia—Dexamethasone—hematologic cancer	0.00028	0.000356	CcSEcCtD
Levorphanol—Dyspepsia—Betamethasone—hematologic cancer	0.00028	0.000356	CcSEcCtD
Levorphanol—Urticaria—Triamcinolone—hematologic cancer	0.000279	0.000354	CcSEcCtD
Levorphanol—Estradiol—ABCB1—hematologic cancer	0.000278	0.0274	CrCbGaD
Levorphanol—Nausea—Mitoxantrone—hematologic cancer	0.000276	0.00035	CcSEcCtD
Levorphanol—Nausea—Irinotecan—hematologic cancer	0.000276	0.00035	CcSEcCtD
Levorphanol—Pruritus—Etoposide—hematologic cancer	0.000274	0.000347	CcSEcCtD
Levorphanol—Shock—Prednisone—hematologic cancer	0.000273	0.000346	CcSEcCtD
Levorphanol—Arrhythmia—Epirubicin—hematologic cancer	0.000273	0.000346	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—hematologic cancer	0.000272	0.000345	CcSEcCtD
Levorphanol—Tachycardia—Prednisone—hematologic cancer	0.000271	0.000343	CcSEcCtD
Levorphanol—Nausea—Gemcitabine—hematologic cancer	0.000269	0.000341	CcSEcCtD
Levorphanol—Vomiting—Cisplatin—hematologic cancer	0.000268	0.000341	CcSEcCtD
Levorphanol—Hyperhidrosis—Prednisone—hematologic cancer	0.000268	0.00034	CcSEcCtD
Levorphanol—Rash—Cisplatin—hematologic cancer	0.000266	0.000338	CcSEcCtD
Levorphanol—Dermatitis—Cisplatin—hematologic cancer	0.000266	0.000337	CcSEcCtD
Levorphanol—Feeling abnormal—Dexamethasone—hematologic cancer	0.000262	0.000333	CcSEcCtD
Levorphanol—Feeling abnormal—Betamethasone—hematologic cancer	0.000262	0.000333	CcSEcCtD
Levorphanol—Flushing—Doxorubicin—hematologic cancer	0.000262	0.000333	CcSEcCtD
Levorphanol—Tension—Epirubicin—hematologic cancer	0.000261	0.000331	CcSEcCtD
Levorphanol—Gastrointestinal pain—Betamethasone—hematologic cancer	0.00026	0.00033	CcSEcCtD
Levorphanol—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.00026	0.00033	CcSEcCtD
Levorphanol—Nervousness—Epirubicin—hematologic cancer	0.000258	0.000327	CcSEcCtD
Levorphanol—Dizziness—Etoposide—hematologic cancer	0.000256	0.000325	CcSEcCtD
Levorphanol—Muscle spasms—Epirubicin—hematologic cancer	0.000255	0.000324	CcSEcCtD
Levorphanol—Urticaria—Betamethasone—hematologic cancer	0.000253	0.000321	CcSEcCtD
Levorphanol—Urticaria—Dexamethasone—hematologic cancer	0.000253	0.000321	CcSEcCtD
Levorphanol—Dizziness—Prednisolone—hematologic cancer	0.000252	0.00032	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—hematologic cancer	0.000252	0.00032	CcSEcCtD
Levorphanol—Abdominal pain—Betamethasone—hematologic cancer	0.000252	0.000319	CcSEcCtD
Levorphanol—Abdominal pain—Dexamethasone—hematologic cancer	0.000252	0.000319	CcSEcCtD
Levorphanol—Nausea—Cisplatin—hematologic cancer	0.000251	0.000318	CcSEcCtD
Levorphanol—Insomnia—Prednisone—hematologic cancer	0.000251	0.000318	CcSEcCtD
Levorphanol—Pruritus—Triamcinolone—hematologic cancer	0.000248	0.000315	CcSEcCtD
Levorphanol—Convulsion—Methotrexate—hematologic cancer	0.000246	0.000312	CcSEcCtD
Levorphanol—Vomiting—Etoposide—hematologic cancer	0.000246	0.000312	CcSEcCtD
Levorphanol—Agitation—Epirubicin—hematologic cancer	0.000244	0.00031	CcSEcCtD
Levorphanol—Dyspepsia—Prednisone—hematologic cancer	0.000244	0.00031	CcSEcCtD
Levorphanol—Rash—Etoposide—hematologic cancer	0.000244	0.000309	CcSEcCtD
Levorphanol—Dermatitis—Etoposide—hematologic cancer	0.000244	0.000309	CcSEcCtD
Levorphanol—Tension—Doxorubicin—hematologic cancer	0.000241	0.000306	CcSEcCtD
Levorphanol—Rash—Prednisolone—hematologic cancer	0.00024	0.000305	CcSEcCtD
Levorphanol—Dermatitis—Prednisolone—hematologic cancer	0.00024	0.000305	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—hematologic cancer	0.000239	0.000303	CcSEcCtD
Levorphanol—Constipation—Prednisone—hematologic cancer	0.000237	0.000301	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—hematologic cancer	0.000236	0.0003	CcSEcCtD
Levorphanol—Palpitations—Epirubicin—hematologic cancer	0.000235	0.000298	CcSEcCtD
Levorphanol—Confusional state—Methotrexate—hematologic cancer	0.000234	0.000296	CcSEcCtD
Levorphanol—Dizziness—Triamcinolone—hematologic cancer	0.000232	0.000294	CcSEcCtD
Levorphanol—Convulsion—Epirubicin—hematologic cancer	0.00023	0.000292	CcSEcCtD
Levorphanol—Nausea—Etoposide—hematologic cancer	0.00023	0.000292	CcSEcCtD
Levorphanol—Feeling abnormal—Prednisone—hematologic cancer	0.000228	0.00029	CcSEcCtD
Levorphanol—Gastrointestinal pain—Prednisone—hematologic cancer	0.000227	0.000288	CcSEcCtD
Levorphanol—Nausea—Prednisolone—hematologic cancer	0.000227	0.000288	CcSEcCtD
Levorphanol—Agitation—Doxorubicin—hematologic cancer	0.000226	0.000287	CcSEcCtD
Levorphanol—Pruritus—Dexamethasone—hematologic cancer	0.000225	0.000286	CcSEcCtD
Levorphanol—Pruritus—Betamethasone—hematologic cancer	0.000225	0.000286	CcSEcCtD
Levorphanol—Hyperhidrosis—Methotrexate—hematologic cancer	0.000224	0.000284	CcSEcCtD
Levorphanol—Vomiting—Triamcinolone—hematologic cancer	0.000223	0.000283	CcSEcCtD
Levorphanol—Rash—Triamcinolone—hematologic cancer	0.000221	0.000281	CcSEcCtD
Levorphanol—Dry mouth—Epirubicin—hematologic cancer	0.000221	0.000281	CcSEcCtD
Levorphanol—Dermatitis—Triamcinolone—hematologic cancer	0.000221	0.00028	CcSEcCtD
Levorphanol—Urticaria—Prednisone—hematologic cancer	0.00022	0.000279	CcSEcCtD
Levorphanol—Abdominal pain—Prednisone—hematologic cancer	0.000219	0.000278	CcSEcCtD
Levorphanol—Confusional state—Epirubicin—hematologic cancer	0.000219	0.000277	CcSEcCtD
Levorphanol—Palpitations—Doxorubicin—hematologic cancer	0.000217	0.000276	CcSEcCtD
Levorphanol—Hypotension—Methotrexate—hematologic cancer	0.000216	0.000275	CcSEcCtD
Levorphanol—Shock—Epirubicin—hematologic cancer	0.000213	0.000271	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—hematologic cancer	0.000213	0.00027	CcSEcCtD
Levorphanol—Tachycardia—Epirubicin—hematologic cancer	0.000212	0.000268	CcSEcCtD
Levorphanol—Dizziness—Dexamethasone—hematologic cancer	0.00021	0.000267	CcSEcCtD
Levorphanol—Dizziness—Betamethasone—hematologic cancer	0.00021	0.000267	CcSEcCtD
Levorphanol—Hyperhidrosis—Epirubicin—hematologic cancer	0.00021	0.000266	CcSEcCtD
Levorphanol—Insomnia—Methotrexate—hematologic cancer	0.00021	0.000266	CcSEcCtD
Levorphanol—Nausea—Triamcinolone—hematologic cancer	0.000208	0.000264	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—hematologic cancer	0.000205	0.00026	CcSEcCtD
Levorphanol—Dyspepsia—Methotrexate—hematologic cancer	0.000204	0.000259	CcSEcCtD
Levorphanol—Hypotension—Epirubicin—hematologic cancer	0.000203	0.000257	CcSEcCtD
Levorphanol—Vomiting—Dexamethasone—hematologic cancer	0.000202	0.000257	CcSEcCtD
Levorphanol—Vomiting—Betamethasone—hematologic cancer	0.000202	0.000257	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—hematologic cancer	0.000202	0.000257	CcSEcCtD
Levorphanol—Rash—Betamethasone—hematologic cancer	0.000201	0.000255	CcSEcCtD
Levorphanol—Rash—Dexamethasone—hematologic cancer	0.000201	0.000255	CcSEcCtD
Levorphanol—Dermatitis—Dexamethasone—hematologic cancer	0.0002	0.000254	CcSEcCtD
Levorphanol—Dermatitis—Betamethasone—hematologic cancer	0.0002	0.000254	CcSEcCtD
Levorphanol—Shock—Doxorubicin—hematologic cancer	0.000197	0.00025	CcSEcCtD
Levorphanol—Pruritus—Prednisone—hematologic cancer	0.000196	0.000249	CcSEcCtD
Levorphanol—Insomnia—Epirubicin—hematologic cancer	0.000196	0.000249	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—hematologic cancer	0.000196	0.000248	CcSEcCtD
Levorphanol—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000194	0.000246	CcSEcCtD
Levorphanol—Feeling abnormal—Methotrexate—hematologic cancer	0.000191	0.000242	CcSEcCtD
Levorphanol—Dyspepsia—Epirubicin—hematologic cancer	0.000191	0.000242	CcSEcCtD
Levorphanol—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000189	0.00024	CcSEcCtD
Levorphanol—Nausea—Betamethasone—hematologic cancer	0.000189	0.00024	CcSEcCtD
Levorphanol—Nausea—Dexamethasone—hematologic cancer	0.000189	0.00024	CcSEcCtD
Levorphanol—Hypotension—Doxorubicin—hematologic cancer	0.000187	0.000238	CcSEcCtD
Levorphanol—Constipation—Epirubicin—hematologic cancer	0.000185	0.000235	CcSEcCtD
Levorphanol—Urticaria—Methotrexate—hematologic cancer	0.000184	0.000234	CcSEcCtD
Levorphanol—Dizziness—Prednisone—hematologic cancer	0.000183	0.000233	CcSEcCtD
Levorphanol—Abdominal pain—Methotrexate—hematologic cancer	0.000183	0.000232	CcSEcCtD
Levorphanol—Insomnia—Doxorubicin—hematologic cancer	0.000181	0.00023	CcSEcCtD
Levorphanol—Feeling abnormal—Epirubicin—hematologic cancer	0.000179	0.000227	CcSEcCtD
Levorphanol—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000177	0.000225	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—hematologic cancer	0.000177	0.000224	CcSEcCtD
Levorphanol—Vomiting—Prednisone—hematologic cancer	0.000176	0.000224	CcSEcCtD
Levorphanol—Rash—Prednisone—hematologic cancer	0.000175	0.000222	CcSEcCtD
Levorphanol—Dermatitis—Prednisone—hematologic cancer	0.000175	0.000222	CcSEcCtD
Levorphanol—Urticaria—Epirubicin—hematologic cancer	0.000172	0.000219	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—hematologic cancer	0.000172	0.000218	CcSEcCtD
Levorphanol—Abdominal pain—Epirubicin—hematologic cancer	0.000171	0.000217	CcSEcCtD
Levorphanol—Feeling abnormal—Doxorubicin—hematologic cancer	0.000165	0.00021	CcSEcCtD
Levorphanol—Nausea—Prednisone—hematologic cancer	0.000165	0.000209	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000164	0.000208	CcSEcCtD
Levorphanol—Pruritus—Methotrexate—hematologic cancer	0.000164	0.000208	CcSEcCtD
Levorphanol—Urticaria—Doxorubicin—hematologic cancer	0.000159	0.000202	CcSEcCtD
Levorphanol—Abdominal pain—Doxorubicin—hematologic cancer	0.000159	0.000201	CcSEcCtD
Levorphanol—Pruritus—Epirubicin—hematologic cancer	0.000153	0.000195	CcSEcCtD
Levorphanol—Dizziness—Methotrexate—hematologic cancer	0.000153	0.000194	CcSEcCtD
Levorphanol—Vomiting—Methotrexate—hematologic cancer	0.000147	0.000187	CcSEcCtD
Levorphanol—Rash—Methotrexate—hematologic cancer	0.000146	0.000185	CcSEcCtD
Levorphanol—Dermatitis—Methotrexate—hematologic cancer	0.000146	0.000185	CcSEcCtD
Levorphanol—Dizziness—Epirubicin—hematologic cancer	0.000143	0.000182	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—hematologic cancer	0.000142	0.00018	CcSEcCtD
Levorphanol—Vomiting—Epirubicin—hematologic cancer	0.000138	0.000175	CcSEcCtD
Levorphanol—Nausea—Methotrexate—hematologic cancer	0.000138	0.000175	CcSEcCtD
Levorphanol—Rash—Epirubicin—hematologic cancer	0.000137	0.000173	CcSEcCtD
Levorphanol—Dermatitis—Epirubicin—hematologic cancer	0.000137	0.000173	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—hematologic cancer	0.000133	0.000168	CcSEcCtD
Levorphanol—Nausea—Epirubicin—hematologic cancer	0.000129	0.000163	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—hematologic cancer	0.000128	0.000162	CcSEcCtD
Levorphanol—Rash—Doxorubicin—hematologic cancer	0.000126	0.00016	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—hematologic cancer	0.000126	0.00016	CcSEcCtD
Levorphanol—Nausea—Doxorubicin—hematologic cancer	0.000119	0.000151	CcSEcCtD
Levorphanol—OPRD1—Signaling Pathways—FGF1—hematologic cancer	5.87e-05	0.000291	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—JAK2—hematologic cancer	5.82e-05	0.000288	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCR4—hematologic cancer	5.81e-05	0.000288	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HDAC2—hematologic cancer	5.81e-05	0.000288	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MAP2K1—hematologic cancer	5.79e-05	0.000287	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FOXO1—hematologic cancer	5.79e-05	0.000287	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—IL2—hematologic cancer	5.78e-05	0.000287	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PDGFRB—hematologic cancer	5.78e-05	0.000286	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GRB2—hematologic cancer	5.76e-05	0.000285	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CD—hematologic cancer	5.75e-05	0.000285	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PDGFA—hematologic cancer	5.75e-05	0.000285	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CB—hematologic cancer	5.72e-05	0.000283	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PDGFRA—hematologic cancer	5.69e-05	0.000282	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PRKCG—hematologic cancer	5.67e-05	0.000281	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—JAK1—hematologic cancer	5.67e-05	0.000281	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KITLG—hematologic cancer	5.67e-05	0.000281	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CBL—hematologic cancer	5.66e-05	0.00028	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL3—hematologic cancer	5.6e-05	0.000277	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT5A—hematologic cancer	5.54e-05	0.000274	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CG—hematologic cancer	5.53e-05	0.000274	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CB—hematologic cancer	5.52e-05	0.000274	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTPN1—hematologic cancer	5.51e-05	0.000273	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN2B—hematologic cancer	5.49e-05	0.000272	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PTPN11—hematologic cancer	5.44e-05	0.000269	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3R1—hematologic cancer	5.43e-05	0.000269	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RASGRP1—hematologic cancer	5.42e-05	0.000268	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HSP90AA1—hematologic cancer	5.4e-05	0.000267	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SYK—hematologic cancer	5.4e-05	0.000267	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CD—hematologic cancer	5.36e-05	0.000265	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CD86—hematologic cancer	5.31e-05	0.000263	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL2RA—hematologic cancer	5.29e-05	0.000262	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—JAK2—hematologic cancer	5.28e-05	0.000262	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CREB1—hematologic cancer	5.27e-05	0.000261	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL2—hematologic cancer	5.25e-05	0.00026	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HES1—hematologic cancer	5.24e-05	0.000259	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TERT—hematologic cancer	5.23e-05	0.000259	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NCOR1—hematologic cancer	5.21e-05	0.000258	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT1—hematologic cancer	5.21e-05	0.000258	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL2—hematologic cancer	5.15e-05	0.000255	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CSF2—hematologic cancer	5.15e-05	0.000255	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGF1—hematologic cancer	5.15e-05	0.000255	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6R—hematologic cancer	5.14e-05	0.000254	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PDGFB—hematologic cancer	5.11e-05	0.000253	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FOXO1—hematologic cancer	5.07e-05	0.000251	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—IL2—hematologic cancer	5.07e-05	0.000251	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PDGFRB—hematologic cancer	5.07e-05	0.000251	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3R1—hematologic cancer	5.06e-05	0.000251	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CB—hematologic cancer	5.02e-05	0.000248	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TSC2—hematologic cancer	4.99e-05	0.000247	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PDGFRA—hematologic cancer	4.99e-05	0.000247	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PRKCG—hematologic cancer	4.97e-05	0.000246	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—JAK1—hematologic cancer	4.97e-05	0.000246	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—JAK2—hematologic cancer	4.92e-05	0.000243	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MAP2K1—hematologic cancer	4.9e-05	0.000243	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GRB2—hematologic cancer	4.87e-05	0.000241	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CD—hematologic cancer	4.86e-05	0.000241	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PDGFA—hematologic cancer	4.86e-05	0.000241	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGFR3—hematologic cancer	4.8e-05	0.000238	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KITLG—hematologic cancer	4.79e-05	0.000237	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK14—hematologic cancer	4.76e-05	0.000236	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT5A—hematologic cancer	4.68e-05	0.000232	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	4.67e-05	0.000231	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ESR1—hematologic cancer	4.67e-05	0.000231	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL2RA—hematologic cancer	4.64e-05	0.00023	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN2B—hematologic cancer	4.64e-05	0.00023	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FN1—hematologic cancer	4.61e-05	0.000228	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL2—hematologic cancer	4.61e-05	0.000228	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3R1—hematologic cancer	4.59e-05	0.000228	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TERT—hematologic cancer	4.59e-05	0.000227	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—BAD—hematologic cancer	4.55e-05	0.000226	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NFKBIA—hematologic cancer	4.55e-05	0.000226	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOTCH1—hematologic cancer	4.51e-05	0.000223	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CD86—hematologic cancer	4.49e-05	0.000222	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PDGFB—hematologic cancer	4.48e-05	0.000222	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—JAK2—hematologic cancer	4.46e-05	0.000221	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HES1—hematologic cancer	4.43e-05	0.000219	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CD80—hematologic cancer	4.42e-05	0.000219	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KIT—hematologic cancer	4.41e-05	0.000218	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CG—hematologic cancer	4.41e-05	0.000218	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—NRAS—hematologic cancer	4.41e-05	0.000218	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	4.4e-05	0.000218	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TSC2—hematologic cancer	4.38e-05	0.000217	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CSF2—hematologic cancer	4.35e-05	0.000216	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGF1—hematologic cancer	4.35e-05	0.000216	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTPN11—hematologic cancer	4.33e-05	0.000215	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	4.29e-05	0.000212	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	4.29e-05	0.000212	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	4.28e-05	0.000212	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	4.24e-05	0.00021	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—MAPK3—hematologic cancer	4.22e-05	0.000209	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	4.21e-05	0.000209	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGFR3—hematologic cancer	4.21e-05	0.000209	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—JAK1—hematologic cancer	4.2e-05	0.000208	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	4.2e-05	0.000208	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CREB1—hematologic cancer	4.2e-05	0.000208	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK14—hematologic cancer	4.17e-05	0.000207	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—BRAF—hematologic cancer	4.15e-05	0.000205	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL2—hematologic cancer	4.11e-05	0.000203	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6R—hematologic cancer	4.09e-05	0.000203	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ESR1—hematologic cancer	4.09e-05	0.000203	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CREBBP—hematologic cancer	4.09e-05	0.000203	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FN1—hematologic cancer	4.04e-05	0.0002	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—BAD—hematologic cancer	3.99e-05	0.000198	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NFKBIA—hematologic cancer	3.99e-05	0.000198	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOTCH1—hematologic cancer	3.95e-05	0.000196	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	3.92e-05	0.000194	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAP2K1—hematologic cancer	3.9e-05	0.000193	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL2—hematologic cancer	3.89e-05	0.000193	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TERT—hematologic cancer	3.88e-05	0.000192	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CD—hematologic cancer	3.88e-05	0.000192	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CD80—hematologic cancer	3.87e-05	0.000192	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CG—hematologic cancer	3.87e-05	0.000192	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KIT—hematologic cancer	3.87e-05	0.000192	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—NRAS—hematologic cancer	3.87e-05	0.000192	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.84e-05	0.00019	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTPN11—hematologic cancer	3.8e-05	0.000188	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—KRAS—hematologic cancer	3.8e-05	0.000188	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	3.79e-05	0.000188	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGF2—hematologic cancer	3.71e-05	0.000184	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MAPK3—hematologic cancer	3.7e-05	0.000183	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TSC2—hematologic cancer	3.7e-05	0.000183	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CREB1—hematologic cancer	3.68e-05	0.000182	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3R1—hematologic cancer	3.66e-05	0.000181	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—BRAF—hematologic cancer	3.63e-05	0.00018	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL2—hematologic cancer	3.6e-05	0.000178	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6R—hematologic cancer	3.59e-05	0.000178	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	3.59e-05	0.000178	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	3.56e-05	0.000176	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—JAK2—hematologic cancer	3.56e-05	0.000176	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	3.52e-05	0.000175	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	3.49e-05	0.000173	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MDM2—hematologic cancer	3.47e-05	0.000172	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ESR1—hematologic cancer	3.46e-05	0.000171	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	3.42e-05	0.00017	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FN1—hematologic cancer	3.41e-05	0.000169	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	3.4e-05	0.000168	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MTOR—hematologic cancer	3.38e-05	0.000167	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	3.38e-05	0.000167	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—BAD—hematologic cancer	3.37e-05	0.000167	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	3.37e-05	0.000167	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.37e-05	0.000167	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	3.34e-05	0.000166	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	3.33e-05	0.000165	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CD80—hematologic cancer	3.27e-05	0.000162	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	3.27e-05	0.000162	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KIT—hematologic cancer	3.27e-05	0.000162	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	3.27e-05	0.000162	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGF2—hematologic cancer	3.25e-05	0.000161	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	3.23e-05	0.00016	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	3.21e-05	0.000159	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	3.21e-05	0.000159	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	3.17e-05	0.000157	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	3.14e-05	0.000155	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	3.13e-05	0.000155	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—JAK2—hematologic cancer	3.12e-05	0.000155	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CREB1—hematologic cancer	3.11e-05	0.000154	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CASP3—hematologic cancer	3.11e-05	0.000154	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL2—hematologic cancer	3.1e-05	0.000154	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6—hematologic cancer	3.09e-05	0.000153	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—BRAF—hematologic cancer	3.07e-05	0.000152	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	3.06e-05	0.000151	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MDM2—hematologic cancer	3.05e-05	0.000151	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL2—hematologic cancer	3.04e-05	0.000151	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6R—hematologic cancer	3.03e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	3.03e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCND1—hematologic cancer	3.03e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—JUN—hematologic cancer	3.02e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MTOR—hematologic cancer	2.96e-05	0.000147	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	2.96e-05	0.000147	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	2.93e-05	0.000145	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTEN—hematologic cancer	2.92e-05	0.000145	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	2.89e-05	0.000143	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	2.87e-05	0.000142	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	2.86e-05	0.000142	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	2.85e-05	0.000141	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.85e-05	0.000141	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	2.83e-05	0.00014	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	2.81e-05	0.000139	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EP300—hematologic cancer	2.78e-05	0.000138	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	2.78e-05	0.000138	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGF2—hematologic cancer	2.75e-05	0.000136	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	2.75e-05	0.000136	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CASP3—hematologic cancer	2.73e-05	0.000135	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL2—hematologic cancer	2.72e-05	0.000135	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	2.71e-05	0.000134	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SRC—hematologic cancer	2.71e-05	0.000134	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6—hematologic cancer	2.71e-05	0.000134	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCND1—hematologic cancer	2.65e-05	0.000131	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—JUN—hematologic cancer	2.65e-05	0.000131	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	2.64e-05	0.000131	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—JAK2—hematologic cancer	2.64e-05	0.000131	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STAT3—hematologic cancer	2.61e-05	0.000129	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NRAS—hematologic cancer	2.61e-05	0.000129	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	2.58e-05	0.000128	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MDM2—hematologic cancer	2.57e-05	0.000128	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	2.57e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTEN—hematologic cancer	2.56e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	2.5e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MTOR—hematologic cancer	2.5e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	2.5e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	2.5e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	2.49e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EP300—hematologic cancer	2.44e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MYC—hematologic cancer	2.43e-05	0.00012	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	2.42e-05	0.00012	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	2.39e-05	0.000118	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SRC—hematologic cancer	2.37e-05	0.000118	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	2.35e-05	0.000116	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	2.32e-05	0.000115	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	2.31e-05	0.000115	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CASP3—hematologic cancer	2.3e-05	0.000114	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL2—hematologic cancer	2.3e-05	0.000114	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT3—hematologic cancer	2.29e-05	0.000113	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6—hematologic cancer	2.29e-05	0.000113	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NRAS—hematologic cancer	2.28e-05	0.000113	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KRAS—hematologic cancer	2.24e-05	0.000111	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCND1—hematologic cancer	2.24e-05	0.000111	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—JUN—hematologic cancer	2.24e-05	0.000111	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	2.19e-05	0.000108	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	2.17e-05	0.000107	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTEN—hematologic cancer	2.16e-05	0.000107	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MYC—hematologic cancer	2.13e-05	0.000105	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	2.12e-05	0.000105	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	2.12e-05	0.000105	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	2.11e-05	0.000105	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EP300—hematologic cancer	2.06e-05	0.000102	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	2.06e-05	0.000102	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SRC—hematologic cancer	2.01e-05	9.94e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TP53—hematologic cancer	1.99e-05	9.87e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KRAS—hematologic cancer	1.97e-05	9.74e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	1.95e-05	9.68e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT3—hematologic cancer	1.94e-05	9.59e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NRAS—hematologic cancer	1.93e-05	9.56e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HRAS—hematologic cancer	1.91e-05	9.44e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	1.85e-05	9.16e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6—hematologic cancer	1.82e-05	9.04e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	1.81e-05	8.95e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MYC—hematologic cancer	1.8e-05	8.91e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	1.79e-05	8.89e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TP53—hematologic cancer	1.75e-05	8.66e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT1—hematologic cancer	1.68e-05	8.34e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HRAS—hematologic cancer	1.67e-05	8.28e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KRAS—hematologic cancer	1.66e-05	8.23e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6—hematologic cancer	1.6e-05	7.92e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.53e-05	7.56e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TP53—hematologic cancer	1.48e-05	7.32e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT1—hematologic cancer	1.48e-05	7.31e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HRAS—hematologic cancer	1.41e-05	7e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6—hematologic cancer	1.35e-05	6.7e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT1—hematologic cancer	1.25e-05	6.18e-05	CbGpPWpGaD
